Episode 251-Deven Patel and Dr. Anand Srivastava on Bringing Advanced Scientific Knowledge to Market

Welcome to Episode 251 of Building My Legacy.

In this podcast we talk with the cofounders of GIOSTAR — the Global Institute of Stem Cell Therapy and Research — the world’s leading stem cell research company. Deven Patel, who manages the business side of GIOSTAR, believes it is possible — through collaboration with governments — to make stem cell based therapies affordable to the victims of degenerative diseases who are unable to afford today’s high cost treatments. Dr. Anand Srivastava, a pioneer who started the modern field of stem cell science 22 years ago, shares with us how the work he’s doing with GIOSTAR can treat degenerative and genetic diseases such as Parkinson’s, Alzheimer’s, autism, diabetes and cancer as well as spinal cord injuries and burns.

So if you want to know:

– The current status of stem cell research and how it has progressed in the last two decades

– How fetal surgery may offer hope to fight genetic diseases

– How collaboration with governments could represent the best chance to successfully treat certain diseases

– The role stem cell therapy has played in treating COVID

– The unique advantage stem cells have over manufactured chemicals

About Deven Patel and Dr. Anand Srivastava

Deven Patel and Dr. Anand Srivastava have worked together for more than 20 years. When they cofounded GIOSTAR, their goal was to take mankind’s most elite, expensive and advanced scientific knowledge and make it available, accessible and affordable to the masses. They’ve worked toward this goal by building their own stem cell research institute in addition to stem cell treatment hospitals to deliver an integrated “research bench to bedside” approach that treats many diseases previously regarded as incurable. More information is available at their company’s website, www.giostar.com

About Lois Sonstegard, PhD

Working with business leaders for more than 30 years, Lois has learned that successful